BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23378853)

  • 21. Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO).
    Salembier C; De Hertogh O; Daisne JF; Palumbo S; Van Gestel D
    Radiother Oncol; 2020 Sep; 150():245-252. PubMed ID: 32679309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
    Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy.
    Pop LA; van den Broek JF; Visser AG; van der Kogel AJ
    Radiother Oncol; 1996 Feb; 38(2):153-62. PubMed ID: 8966228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of methods for the measurement of radiation dose distributions in high dose rate (HDR) brachytherapy: Ge-doped optical fiber, EBT3 Gafchromic film, and PRESAGE® radiochromic plastic.
    Palmer AL; Di Pietro P; Alobaidli S; Issa F; Doran S; Bradley D; Nisbet A
    Med Phys; 2013 Jun; 40(6):061707. PubMed ID: 23718586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDR and PDR
    Zwierzchowski G; Błasiak B; Stefaniak P; Bielęda G
    J Contemp Brachytherapy; 2009 Oct; 1(3):157-162. PubMed ID: 27807459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
    Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
    Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple calibration routine for small inorganic scintillation detectors for in vivo dosimetry during brachytherapy.
    Georgi PD; Jørgensen EB; Heidotting M; Tanderup K; Kertzscher G; Johansen JG
    Brachytherapy; 2024 Jun; ():. PubMed ID: 38853063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer.
    Berenguer Frances MA; Linares-Galiana I; Cañas Cortés R; Marín I Borrás S; Gutiérrez Miguélez C; Najjari D; Slocker A; Bellobí C; Santacana M; Pané Foix M; Alonso MH; Navarro-Martin A; Comas Antón S; Guedea F
    Brachytherapy; 2020; 19(1):51-59. PubMed ID: 31690516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis.
    Hermesse J; Pleyers C; Gennigens C; De Cuypere M; Lovinfosse P; Seidel Statistician L; Coucke P; Kridelka F
    Strahlenther Onkol; 2023 Feb; 199(2):141-148. PubMed ID: 35943555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of kilovoltage (kV) radiotherapy in the UK: installed equipment, clinical workload, physics quality control and radiation dosimetry.
    Palmer AL; Pearson M; Whittard P; McHugh KE; Eaton DJ
    Br J Radiol; 2016 Dec; 89(1068):20160641. PubMed ID: 27730839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
    Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practices of radiotherapy equipment quality control in radiotherapy centres in Croatia.
    Svabić M; Jurković S; Faj D; Kasabasić M; Smilović Radojcić D; Ivković A
    Coll Antropol; 2008 Oct; 32 Suppl 2():217-9. PubMed ID: 19138027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Audit on source strength determination for HDR and PDR (192)Ir brachytherapy in Sweden.
    Carlsson Tedgren A; Grindborg JE
    Radiother Oncol; 2008 Jan; 86(1):126-30. PubMed ID: 18187219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
    Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates.
    Vijande J; Carlsson Tedgren Å; Ballester F; Baltas D; Papagiannis P; Rivard MJ; Siebert FA; De Werd L; Perez-Calatayud J
    Phys Imaging Radiat Oncol; 2021 Jul; 19():108-111. PubMed ID: 34401536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IPEM topical report: results of a 2022 UK survey on the use of linac manufacturer integrated quality control (MIQC).
    Pearson M; Barnes MP; Brown KF; Hawthorn K; Stevens SW; Kizhakke Veetil R; Weston S; Whitbourn JR
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37988759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study.
    Kumar P; Sharma DN; Kumar S; Gandhi AK; Rath GK; Julka PK
    Brachytherapy; 2016; 15(3):327-332. PubMed ID: 26996595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques.
    Palmer A; Bradley D; Nisbet A
    J Contemp Brachytherapy; 2012 Jun; 4(2):81-91. PubMed ID: 23349649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016.
    Corey G; Yoosuf ABM; Workman G; Byrne M; Mitchell DM; Jain S
    J Contemp Brachytherapy; 2018 Jun; 10(3):238-245. PubMed ID: 30038644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IPEM Topical Report: A 2018 IPEM survey of MRI use for external beam radiotherapy treatment planning in the UK.
    Speight R; Schmidt MA; Liney GP; Johnstone RI; Eccles CL; Dubec M; George B; Henry A; McCallum H
    Phys Med Biol; 2019 Sep; 64(17):175021. PubMed ID: 31239419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.